It would be nice to know what Anavex’s growth strategy actually is, other than slow walking lead programs and adding more and more programs while expanding staff to make Anavex look more substantial than it actually is.
Instead of a growth strategy (which screams ever-increasing expenses and increased dilution), I’d like to hear about the clinical trial strategy, the regulatory strategy, the partnering strategy, and the commercialization strategy.
News 
Market Data 
Discover 
